Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Assessing Risk Behaviours in the Iranian General Population: Results From the Iranian Mental Health Survey; [Evaluation Des Comportements a Risque Dans La Population Generale Iranienne: Resultats De L’Enquete Iranienne Sur La Sante Mentale]
Afarin Rahimi-Movaghar
Afarin Rahimi-Movaghar

Professor of Psychiatry

Iranian National Center for Addiction Studies (INCAS)

Tehran University of Medical Sciences

Related Documents
1. Assessing Risk Behaviours in the Iranian General Population: Results From the Iranian Mental Health Survey; [Evaluation Des Comportements a Risque Dans La Population Generale Iranienne: Resultats De L’Enquete Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2021)
2. Profile of Drug Users in the Residential Treatment Centers of Tehran, Iran, Health Promotion Perspectives (2019)
3. Hepatitis B Virus Infection Among People Who Use Drugs in Iran: A Systematic Review, Meta-Analysis, and Trend Analysis, Harm Reduction Journal (2020)
4. Profile of People Who Inject Drugs in Tehran, Iran, Acta Medica Iranica (2016)
5. Hiv Prevalence Among Non-Injecting People Who Use Drugs and Related Factors in Iran: A Systematic Review and Meta-Analysis, Drug and Alcohol Review (2022)
6. Public Health Risks Associated With Methadone in Iran: A Systematic Review and Meta-Analysis, International Journal of Drug Policy (2022)
7. Evidence for an Increase in Cannabis Use in Iran – a Systematic Review and Trend Analysis, PLoS ONE (2021)
8. Buprenorphine Abuse and Health Risks in Iran: A Systematic Review, Drug and Alcohol Dependence (2021)
9. Hiv Prevention Cascades for Injection and Sexual Risk Behaviors Among Hiv-Negative People Who Inject Drug in Iran, International Journal of Drug Policy (2020)
10. The Evolution of Addiction Treatment and Harm Reduction Programs in Iran: A Chaotic Response or a Synergistic Diversity?, Addiction (2020)
11. Out-Of-Pocket Cost of Drug Abuse Consequences: Results From Iranian National Mental Health Survey; [Cout Des Paiements Directs Engendres Par L’Abus De Substances Psychoactives: Resultats De L’Enquete Nationale Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2017)
12. Transition to and Away From Injecting Drug Use Among Young Drug Users in Tehran, Iran: A Qualitative Study, Iranian Journal of Psychiatry and Behavioral Sciences (2017)
13. Use of Amphetamine-Type Stimulants in the Islamic Republic of Iran, 2004–2015: A Review; [Consommation De Stimulants De Type Amphetamines En Republique Islamique D’Iran, 2004-2005: Analyse], Eastern Mediterranean Health Journal (2017)
14. Correlation of Mental Illness and Hiv/Aids Infection, Tehran University Medical Journal (2016)
15. Hiv Prevalence Among People Who Inject Drugs (Pwid) and Related Factors in Iran: A Systematic Review, Meta-Analysis and Trend Analysis, Addiction (2020)
16. Transition to Injecting Drug Use in Iran: A Systematic Review of Qualitative and Quantitative Evidence, International Journal of Drug Policy (2015)
17. Psychiatric Disorders Among People Living With Hiv/Aids in Iran: Prevalence, Severity, Service Utilization and Unmet Mental Health Needs, Journal of Psychosomatic Research (2018)
18. Six-Year Follow-Up of People Who Use Methamphetamine in Iran: A Case Series Study, International Journal of High Risk Behaviors and Addiction (2023)
19. Prevalence and Determinants of Opioid Use Disorder Among Long-Term Opiate Users in Golestan Cohort Study, BMC Psychiatry (2023)
20. Sensitivity of Self-Reported Opioid Use in Case-Control Studies: Healthy Individuals Versus Hospitalized Patients, PLoS ONE (2017)
21. Mortality and Negative Outcomes of Opioid Use and Opioid Use Disorder: A 6-Year Follow-Up Study, Addiction (2022)
All Documents
1. Alcohol Use, Alcohol Use Disorder and Heavy Episodic Drinking in the Eastern Mediterranean Region: A Systematic Review, Addiction (2024)
2. Drug Use and Its Correlated Factors Among University Students in Tehran, Journal of Substance Use (2024)
3. Forecasting the Effects of Smoking Prevalence Scenarios on Years of Life Lost and Life Expectancy From 2022 to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Public Health (2024)
4. The Effectiveness of Universal Educational Interventions for Prevention of Illicit Drug Use Among University Students: A Systematic Review, Iranian Journal of Public Health (2024)
5. World Addiction Medicine Reports: Formation of the International Society of Addiction Medicine Global Expert Network (Isam-Gen) and Its Global Surveys, Frontiers in Psychiatry (2024)
6. A Cascade Analysis of Community Transmission Risks for Hiv Among People Who Inject Drugs Living With Hiv in Iran, Biomedical and Environmental Sciences (2023)
7. Blended Smartphone Intervention for Patients in Opioid Maintenance Treatment in Iran: Protocol for a Randomized Controlled Trial, BMC Psychiatry (2023)
8. Co-Occurrence of Aggression and Suicide Attempt Among Young People and Related Factors: Findings From Iranian Youth Cohort Study in Ravansar, Archives of Iranian Medicine (2023)
9. Commentary on Nikoo Et Al.: Challenges in Protocol Development to Optimize Outcomes of Opium Tincture Maintenance Treatment, Addiction (2023)
10. Development and Psychometric Evaluation of a Dsm-V-Based Social Networking Site Use Disorder Test: The Sns-Dt-10, Psychological Reports (2023)
11. Drug Use, Drug Use Disorders, and Treatment Services in the Eastern Mediterranean Region: A Systematic Review, The Lancet Psychiatry (2023)
12. Iran Quality of Care in Medicine Program (Iqcamp): Design and Outcomes, Archives of Iranian Medicine (2023)
13. Management of Gabapentin Misuse in a Patient With Previous History of Opioid Use Disorder: Case Report, Asian Journal of Psychiatry (2023)
14. Online Gaming and Internet Gaming Disorder in Iran: Patterns, Motivations, and Correlates, Current Psychology (2023)
15. Opium Use and Risk of Colorectal Cancer: A Multi-Center Case-Referent Study in Iran, Acta Oncologica (2023)
16. Opium Use and Risk of Lung Cancer: A Multicenter Case-Control Study in Iran, International Journal of Cancer (2023)
17. Physical Activity Patterns, Circadian Rhythms, and Aggressive and Suicidal Behavior Among a Larger Sample of the General Population Aged 15 to 34 Years, Journal of Clinical Medicine (2023)
18. Prevalence and Determinants of Opioid Use Disorder Among Long-Term Opiate Users in Golestan Cohort Study, BMC Psychiatry (2023)
19. Prevalence of Injecting Drug Use and Hiv, Hepatitis B, and Hepatitis C in People Who Inject Drugs in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis, The Lancet Global Health (2023)
20. Prevalence, Pattern, and Associated Factors of Alcohol Use Disorder Among Male Treatment-Seeking People With Illicit Drug Use Disorder in Tehran, Iran, Journal of Substance Use (2023)
21. Psychometric Properties of the Persian Version of the Gaming Motivation Scale, Psychiatry Investigation (2023)
22. Six-Year Follow-Up of People Who Use Methamphetamine in Iran: A Case Series Study, International Journal of High Risk Behaviors and Addiction (2023)
23. The Carcinogenicity of Opium Consumption: A Systematic Review and Meta-Analysis, European Journal of Epidemiology (2023)
24. Brief Overview of the Who Collaborative Project on the Development of New International Screening and Diagnostic Instruments for Gaming Disorder and Gambling Disorder, Addiction (2022)
25. Comparison of Self-Reported Substance Use With Biological Testing Among Treatment-Seeking Patients With Opioid Use Disorder, Journal of Substance Abuse Treatment (2022)
26. Hiv Prevalence Among Non-Injecting People Who Use Drugs and Related Factors in Iran: A Systematic Review and Meta-Analysis, Drug and Alcohol Review (2022)
27. Mortality and Negative Outcomes of Opioid Use and Opioid Use Disorder: A 6-Year Follow-Up Study, Addiction (2022)
28. Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran, International Journal of Epidemiology (2022)
29. Psychometric Assessment of the Motives for Online Gaming Questionnaire Among Iranian Gamers, Psychiatry Investigation (2022)
30. Public Health Risks Associated With Methadone in Iran: A Systematic Review and Meta-Analysis, International Journal of Drug Policy (2022)
31. Assessing Risk Behaviours in the Iranian General Population: Results From the Iranian Mental Health Survey; [Evaluation Des Comportements a Risque Dans La Population Generale Iranienne: Resultats De L’Enquete Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2021)
32. Assessing Risk Behaviours in the Iranian General Population: Results From the Iranian Mental Health Survey; [Evaluation Des Comportements a Risque Dans La Population Generale Iranienne: Resultats De L’Enquete Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2021)
33. Buprenorphine Abuse and Health Risks in Iran: A Systematic Review, Drug and Alcohol Dependence (2021)
34. Cluster Analysis of Risky Behaviors Among the Youth in Western Iran: Determining Correlates and Comparing Clusters Based on Severity of Disability and Attitude Toward Mental Health Help-Seeking, Indian Journal of Psychiatry (2021)
35. Evidence for an Increase in Cannabis Use in Iran – a Systematic Review and Trend Analysis, PLoS ONE (2021)
36. Expert Appraisal of Criteria for Assessing Gaming Disorder: An International Delphi Study, Addiction (2021)
37. Metabolomics Reveals Biomarkers of Opioid Use Disorder, Translational Psychiatry (2021)
38. Modelling the Intervention Effect of Opioid Agonist Treatment on Multiple Mortality Outcomes in People Who Inject Drugs: A Three-Setting Analysis, The Lancet Psychiatry (2021)
39. Opium Dependence and the Potential Impact of Changes in Treatment Coverage Level: A Dynamic Modeling Study, Health Promotion Perspectives (2021)
40. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)
41. Opium Use Reporting Error in Case-Control Studies: Neighborhood Controls Versus Hospital Visitor Controls, Medical Journal of the Islamic Republic of Iran (2021)
42. Reasons for Not Using Condoms by People Who Inject Drugs in Iran; Results From a Conventional Content Analysis in 2018, Iranian Journal of Epidemiology (2021)
43. The Iranian Study of Opium and Cancer (Iropican): Rationale, Design, and Initial Findings, Archives of Iranian Medicine (2021)
44. Validity of Self-Reported Substance Use: Research Setting Versus Primary Health Care Setting, Substance Abuse: Treatment# Prevention# and Policy (2021)
45. Alcohol Use Disorders Identification Test (Audit): Validation of the Persian Version in an Iranian Population, Alcohol (2020)
46. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
47. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
48. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
49. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
50. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
51. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
52. Hepatitis B Virus Infection Among People Who Use Drugs in Iran: A Systematic Review, Meta-Analysis, and Trend Analysis, Harm Reduction Journal (2020)
53. Hiv Prevalence Among People Who Inject Drugs (Pwid) and Related Factors in Iran: A Systematic Review, Meta-Analysis and Trend Analysis, Addiction (2020)
54. Hiv Prevention Cascades for Injection and Sexual Risk Behaviors Among Hiv-Negative People Who Inject Drug in Iran, International Journal of Drug Policy (2020)
55. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
56. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
57. Preventing Problematic Internet Use During the Covid-19 Pandemic: Consensus Guidance, Comprehensive Psychiatry (2020)
58. The Evolution of Addiction Treatment and Harm Reduction Programs in Iran: A Chaotic Response or a Synergistic Diversity?, Addiction (2020)
59. Tramadol Use and Public Health Consequences in Iran: A Systematic Review and Meta-Analysis, Addiction (2020)
60. A Public Health Approach to Alcohol Use and Its Related Harms in Iran, The Lancet Public Health (2019)
61. An Exploratory Study of Units of Reporting Opium Usein Iran: Implications for Epidemiologic Studies, Archives of Iranian medicine (2019)
62. An Intervention to Improve Hcv Testing, Linkage to Care, and Treatment Among People Who Use Drugs in Tehran, Iran: The Enhance Study, International Journal of Drug Policy (2019)
63. Association of Socioeconomic Status With Consumption of Cigarettes, Illicit Drugs, and Alcohol, Journal of Ethnicity in Substance Abuse (2019)
64. Epidemiological Challenges in the Study of Behavioral Addictions: A Call for High Standard Methodologies, Current Addiction Reports (2019)
65. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
66. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
67. Global Patterns of Opioid Use and Dependence: Harms to Populations, Interventions, and Future Action, The Lancet (2019)
68. Global, Regional, and National Burden of Suicide Mortality 1990 to 2016: Systematic Analysis for the Global Burden of Disease Study 2016, BMJ (Online) (2019)
69. Global, Regional, and National Burden of Traumatic Brain Injury and Spinal Cord Injury, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
70. Global, Regional, and National Incidence, Prevalence, and Mortality of Hiv, 1980-2017, and Forecasts to 2030, for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, The Lancet HIV (2019)
71. Innovations and Changes in the Icd-11 Classification of Mental, Behavioural and Neurodevelopmental Disorders, World Psychiatry (2019)
72. Iran in Transition, The Lancet (2019)
73. Iran in Transition, The Lancet (2019)
74. Mental Health Services for Youth in the Eastern Mediterranean Region: Challenges and Opportunities, Eastern Mediterranean Health Journal (2019)
75. Prevalence of Psychiatric Disorders and Associated Factors Among the Youth in Ravansar, Iran, Archives of Iranian medicine (2019)
76. Profile of Drug Users in the Residential Treatment Centers of Tehran, Iran, Health Promotion Perspectives (2019)
77. Province-Level Prevalence of Psychiatric Disorders: Application of Small-Area Methodology to the Iranian Mental Health Survey (Iranmhs), Iranian Journal of Psychiatry (2019)
78. Sensitivity of Crosswise Model to Simplistic Selection of Nonsensitive Questions: An Application to Estimate Substance Use, Alcohol Consumption and Extramarital Sex Among Iranian College Students, Substance Use and Misuse (2019)
79. Ten-Item Internet Gaming Disorder Test (Igdt-10): Measurement Invariance and Cross-Cultural Validation Across Seven Language-Based Samples, Psychology of Addictive Behaviors (2019)
80. The Risk Environments of People Who Use Drugs Accessing Two Harm Reduction Centers in Tehran, Iran: A Qualitative Study, International Journal of Drug Policy (2019)
81. Μ-Opioid Receptor in the Ca1 Involves in Tramadol and Morphine Cross State-Dependent Memory, Neuroscience Letters (2019)
82. Adaptation and Validation of Short Scales for Assessment of Psychological Distress in Iran: The Persian K10 and K6, International Journal of Methods in Psychiatric Research (2018)
83. Alcohol Use and Burden for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2018)
84. Alcohol Use and Burden for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2018)
85. Ambiguities in Existing Iranian National Policies Addressing Excessive Gaming Commentary On: Policy Responses to Problematic Video Game Use: A Systematic Review of Current Measures and Future Possibilities (Kiraly Et Al., 2018), Journal of Behavioral Addictions (2018)
86. An Ad Hoc Method for Dual Adjusting for Measurement Errors and Nonresponse Bias for Estimating Prevalence in Survey Data: Application to Iranian Mental Health Survey on Any Illicit Drug Use, Statistical Methods in Medical Research (2018)
87. Bipolar Features in Major Depressive Disorder: Results From the Iranian Mental Health Survey (Iranmhs), Journal of Affective Disorders (2018)
88. Cluster Analysis of Psychiatric Profile, Its Correlates, and Using Mental Health Services Among the Young People Aged 15–34: Findings From the First Phase of Iranian Youth Cohort in Ravansar, Social Psychiatry and Psychiatric Epidemiology (2018)
89. Crystal Methamphetamine Use and Its Correlates in Women Engaged in Sex Work in a Developing Country Setting, Drug and Alcohol Dependence (2018)
90. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
91. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
92. Factors Influencing Transition to Shisheh (Methamphetamine) Among Young People Who Use Drugs in Tehran: A Qualitative Study, Journal of Psychoactive Drugs (2018)
93. Global Mortality From Firearms, 1990-2016, JAMA - Journal of the American Medical Association (2018)
94. Global Scientific Production on Illicit Drug Addiction: A Two-Decade Analysis, European Addiction Research (2018)
95. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
96. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
97. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
98. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
99. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
100. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
101. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
102. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
103. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
104. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
105. Incidence and Cost of Non-Fatal Burns in Iran: A Nationwide Population-Based Study, International Journal of Injury Control and Safety Promotion (2018)
106. Including Gaming Disorder in the Icd-11: The Need to Do so From a Clinical and Public Health Perspective: Commentary On: A Weak Scientific Basis for Gaming Disorder: Let Us Err on the Side of Caution (Van Rooij Et Al., 2018), Journal of Behavioral Addictions (2018)
107. Intentional Injuries in the Eastern Mediterranean Region, 1990–2015: Findings From the Global Burden of Disease 2015 Study, International Journal of Public Health (2018)
108. Major Anxiety Disorders in Iran: Prevalence, Sociodemographic Correlates and Service Utilization, BMC Psychiatry (2018)
109. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
110. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
111. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
112. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
113. Methods for Calculation of Per Capita Alcohol Consumption in a Muslim Majority Country With a Very Low Drinking Level: Findings From the 2011 Iranian Mental Health Survey, Drug and Alcohol Review (2018)
114. Pattern of Substance Use Among Students of Medical Sciences in Tehran, Iran: A Latent Class Analysis, Journal of Substance Use (2018)
115. Pharmacological Therapies for Management of Opium Withdrawal, Cochrane Database of Systematic Reviews (2018)
116. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
117. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
118. Prevalence and Costs of Complementary/Alternative Medicine Among Traumatic Patients in Iran: A Nationwide Population-Based Study, Iranian Journal of Public Health (2018)
119. Prospective Epidemiological Research Studies in Iran (The Persian Cohort Study): Rationale, Objectives, and Design, American Journal of Epidemiology (2018)
120. Prospective Epidemiological Research Studies in Iran (The Persian Cohort Study): Rationale, Objectives, and Design, American Journal of Epidemiology (2018)
121. Psychiatric Disorders Among People Living With Hiv/Aids in Iran: Prevalence, Severity, Service Utilization and Unmet Mental Health Needs, Journal of Psychosomatic Research (2018)
122. Setting Research Priorities to Achieve Long-Term Health Targets in Iran, Journal of Global Health (2018)
123. Setting Research Priorities to Achieve Long-Term Health Targets in Iran, Journal of Global Health (2018)
124. Alcohol Use Disorders in Iran: Prevalence, Symptoms, Correlates, and Comorbidity, Drug and Alcohol Dependence (2017)
125. An Overview of the Tools and Screening Tests for Detection of Alcohol Disorders, Iranian Journal of Epidemiology (2017)
126. Depression Improvement Among Patients With Hiv and Endocrine Dysfunction After Hormone Therapy, Iranian Red Crescent Medical Journal (2017)
127. Direct and Indirect Costs of Nonfatal Road Traffic Injuries in Iran: A Population-Based Study, Traffic Injury Prevention (2017)
128. Drop-Out From a Drug Treatment Clinic and Associated Reasons; [Taux D’Abandon Dans Un Centre De Traitement De La Dependance Aux Drogues Et Raisons Associees], Eastern Mediterranean Health Journal (2017)
129. Explaining Socioeconomic Inequalities in Illicit Drug Use Disorders in Iran, Medical Journal of the Islamic Republic of Iran (2017)
130. Gaming Disorder: Its Delineation As an Important Condition for Diagnosis, Management, and Prevention, Journal of Behavioral Addictions (2017)
131. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
132. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
133. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
134. Global, Regional, and National Under-5 Mortality, Adult Mortality, Age-Specific Mortality, and Life Expectancy, 1970-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
135. Inclusion of Gaming Disorder in the Diagnostic Classifications and Promotion of Public Health Response, Journal of Behavioral Addictions (2017)
136. Out-Of-Pocket Cost of Drug Abuse Consequences: Results From Iranian National Mental Health Survey; [Cout Des Paiements Directs Engendres Par L’Abus De Substances Psychoactives: Resultats De L’Enquete Nationale Iranienne Sur La Sante Mentale], Eastern Mediterranean Health Journal (2017)
137. Sensitivity of Self-Reported Opioid Use in Case-Control Studies: Healthy Individuals Versus Hospitalized Patients, PLoS ONE (2017)
138. The Prevalence of Illicit Substance Use Among Students of Medical Sciences in Tehran: Results From Four Repeated Surveys From 2006 to 2009, Journal of Child and Adolescent Substance Abuse (2017)
139. Transition to and Away From Injecting Drug Use Among Young Drug Users in Tehran, Iran: A Qualitative Study, Iranian Journal of Psychiatry and Behavioral Sciences (2017)
140. Use of Amphetamine-Type Stimulants in the Islamic Republic of Iran, 2004–2015: A Review; [Consommation De Stimulants De Type Amphetamines En Republique Islamique D’Iran, 2004-2005: Analyse], Eastern Mediterranean Health Journal (2017)
141. Use of Amphetamine-Type Stimulants in the Islamic Republic of Iran, 2004–2015: A Review; [Consommation De Stimulants De Type Amphetamines En Republique Islamique D’Iran, 2004-2005: Analyse], Eastern Mediterranean Health Journal (2017)
142. Breaking Hiv News to Clients: Spikes Strategy in Post-Test Counseling Session, Acta Medica Iranica (2016)
143. Correlation of Mental Illness and Hiv/Aids Infection, Tehran University Medical Journal (2016)
144. Epidemiology of Illicit Drug Use Disorders in Iran: Prevalence, Correlates, Comorbidity and Service Utilization Results From the Iranian Mental Health Survey, Addiction (Abingdon# England) (2016)
145. Factors Associated With Suicidal Attempts in Iran: A Systematic Review, Iranian Journal of Psychiatry and Behavioral Sciences (2016)
146. Incidence of Fall-Related Injuries in Iran: A Population-Based Nationwide Study, Injury (2016)
147. Prevalence of Hookah Smoking and Its Related Factors Among Students of Tehran University of Medical Sciences, 2012-2013, Iranian Journal of Psychiatry and Behavioral Sciences (2016)
148. Profile of People Who Inject Drugs in Tehran, Iran, Acta Medica Iranica (2016)
149. Psychiatric Disorders Are Associated With an Increased Risk of Injuries: Data From the Iranian Mental Health Survey (Iranmhs), Iranian Journal of Public Health (2016)
150. Subgrouping of Risky Behaviors Among Iranian College Students: A Latent Class Analysis, Neuropsychiatric Disease and Treatment (2016)
151. A 5-Year Scientometric Analysis of Research Centers Affiliated to Tehran University of Medical Sciences, Medical Journal of the Islamic Republic of Iran (2015)
152. A Tentative Component Analysis of Norjizak: A New Abused Drug in Iran, Pakistan Journal of Pharmaceutical Sciences (2015)
153. Age, Period, and Cohort Effects on Alcohol and Drug Use Among Students of Tehran University of Medical Sciences From 2006 to 2009, Iranian Journal of Epidemiology (2015)
154. High Hepatitis C Virus Prevalence Among Drug Users in Iran: Systematic Review and Meta-Analysis of Epidemiological Evidence (2001-2012), International Journal of Infectious Diseases (2015)
155. Incidence of Self-Reported Interpersonal Violence Related Physical Injury in Iran, Iranian Red Crescent Medical Journal (2015)
156. Integrating a Suicide Prevention Program Into the Primary Health Care Network: A Field Trial Study in Iran, BioMed Research International (2015)
157. Latent Class Analysis of Dsm-5 Criteria for Opioid Use Disorders: Results From the Iranian National Survey on Mental Health, European Addiction Research (2015)
158. Population-Based Incidence and Cost of Non-Fatal Injuries in Iran: A Consistent Under-Recognized Public Health Concern, Public Health (2015)
159. Prescription Drugs, Alcohol, and Illicit Substance Use and Their Correlations Among Medical Sciences Students in Iran, International Journal of High Risk Behaviors and Addiction (2015)
160. Scientometrics: Review of Concepts, Applications, and Indicators, Iranian Journal of Epidemiology (2015)
161. Transition to Injecting Drug Use in Iran: A Systematic Review of Qualitative and Quantitative Evidence, International Journal of Drug Policy (2015)
162. Twelve-Month Prevalence and Correlates of Psychiatric Disorders in Iran: The Iranian Mental Health Survey, 2011, Archives of Iranian Medicine (2015)